Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Jensen

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
The Spine Journal : Official Journal of the North American Spine Society|January 23, 2024
Getting what you pay for: impact of copayments on physical therapy and opioid initiation, timing, and continuation for newly diagnosed low back painMichael C Jin, Michael Jensen, Maria Isabel Barros Guinle, et al.
JAMA Network Open|July 11, 2022
Health Care Resource Utilization in Management of Opioid-Naive Patients With Newly Diagnosed Neck PainMichael C Jin, Michael Jensen, Zeyi Zhou, et al.
Journal for Immunotherapy of Cancer|December 15, 2022
Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19<sup>+</sup> malignancyChristopher A Pennell, Heather Campbell, Meghan D Storlie, et al.
Plos One|July 9, 2011
A flexible approach for highly multiplexed candidate gene targeted resequencingGeorges Natsoulis, John M Bell, Hua Xu, et al.
Addiction Science & Clinical Practice|February 7, 2014
Effects of therapeutic goal management (TGM) on treatment attendance and drug abstinence among men with co-occurring substance use and axis I mental disorders who are homeless: results of the Birmingham EARTH programAnna Davidson, Michael Jensen, Emilee Burgess, et al.
Human Gene Therapy|August 10, 2007
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domainsJinjuan Wang, Michael Jensen, Yukang Lin, et al.
Neuron|October 8, 2013
Cornichons control ER export of AMPA receptors to regulate synaptic excitabilityPenelope J Brockie, Michael Jensen, Jerry E Mellem, et al.
Surgery|October 6, 2018
Serum FABP4 concentrations decrease after Roux-en-Y gastric bypass but not after intensive medical managementCyrus Jahansouz, Hongliang Xu, Scott Kizy, et al.
Research Square|October 27, 2023
Context-specific synthetic T cell promoters from assembled transcriptional elementsJacob Appelbaum, Jia Wei, Rithun Mukherjee, et al.
Blood Advances|August 12, 2024
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALLColleen Annesley, Adam Lamble, Corinne Summers, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
The Spine Journal : Official Journal of the North American Spine Society|January 23, 2024
Getting what you pay for: impact of copayments on physical therapy and opioid initiation, timing, and continuation for newly diagnosed low back painMichael C Jin, Michael Jensen, Maria Isabel Barros Guinle, et al.
JAMA Network Open|July 11, 2022
Health Care Resource Utilization in Management of Opioid-Naive Patients With Newly Diagnosed Neck PainMichael C Jin, Michael Jensen, Zeyi Zhou, et al.
Journal for Immunotherapy of Cancer|December 15, 2022
Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19<sup>+</sup> malignancyChristopher A Pennell, Heather Campbell, Meghan D Storlie, et al.
Plos One|July 9, 2011
A flexible approach for highly multiplexed candidate gene targeted resequencingGeorges Natsoulis, John M Bell, Hua Xu, et al.
Addiction Science & Clinical Practice|February 7, 2014
Effects of therapeutic goal management (TGM) on treatment attendance and drug abstinence among men with co-occurring substance use and axis I mental disorders who are homeless: results of the Birmingham EARTH programAnna Davidson, Michael Jensen, Emilee Burgess, et al.
Human Gene Therapy|August 10, 2007
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domainsJinjuan Wang, Michael Jensen, Yukang Lin, et al.
Neuron|October 8, 2013
Cornichons control ER export of AMPA receptors to regulate synaptic excitabilityPenelope J Brockie, Michael Jensen, Jerry E Mellem, et al.
Surgery|October 6, 2018
Serum FABP4 concentrations decrease after Roux-en-Y gastric bypass but not after intensive medical managementCyrus Jahansouz, Hongliang Xu, Scott Kizy, et al.
Research Square|October 27, 2023
Context-specific synthetic T cell promoters from assembled transcriptional elementsJacob Appelbaum, Jia Wei, Rithun Mukherjee, et al.
Blood Advances|August 12, 2024
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALLColleen Annesley, Adam Lamble, Corinne Summers, et al.
Pageof 9